AMGEN Inc (NASDAQ: AMGN) flaunted slowness of -1.85% at $336.07, as the Stock market unbolted on Thursday, before settling in for the price of $342.4 at the close. Taking a more long-term approach, AMGN posted a 52-week range of $253.30-$345.84.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -10.10%. Meanwhile, its Annual Earning per share during the time was -10.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 7.16%. This publicly-traded company’s shares outstanding now amounts to $538.50 million, simultaneously with a float of $537.37 million. The organization now has a market capitalization sitting at $180.97 billion. At the time of writing, stock’s 50-day Moving Average stood at $299.77, while the 200-day Moving Average is $294.51.
AMGEN Inc (AMGN) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the AMGEN Inc industry. AMGEN Inc’s current insider ownership accounts for 0.21%, in contrast to 81.25% institutional ownership. Preceding that transaction, on Nov 12 ’25, Company’s SVP, Business Development sold 890 for 336.24, making the whole transaction’s value amount to 299,256. This particular insider is now the holder of 7,082 in total.
AMGEN Inc (AMGN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.06 per share during the current fiscal year.
AMGEN Inc’s EPS increase for this current 12-month fiscal period is 7.16% and is forecasted to reach 21.78 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 4.35% through the next 5 years, which can be compared against the -10.10% growth it accomplished over the previous five years trading on the market.
AMGEN Inc (NASDAQ: AMGN) Trading Performance Indicators
Let’s observe the current performance indicators for AMGEN Inc (AMGN). It’s Quick Ratio in the last reported quarter now stands at 0.99. Alongside those numbers, its PE Ratio stands at $25.98, and its Beta score is 0.41. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.04. Similarly, its price to free cash flow for trailing twelve months is now 15.68.
In the same vein, AMGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 12.94, a figure that is expected to reach 4.72 in the next quarter, and analysts are predicting that it will be 21.78 at the market close of one year from today.
Technical Analysis of AMGEN Inc (AMGN)
Now, what If we examine the latest scores posted by [AMGEN Inc, AMGN]. During the last 5-days, its volume was better the volume of 2.75 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 82.17% While, its Average True Range was 66.16.
Raw Stochastic average of AMGEN Inc (AMGN) in the period of the previous 100 days is set at 87.16%, which indicates a major rise in contrast to 81.81% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 9.13 that was higher than 6.46 volatility it exhibited in the past 100-days period.
